Indication

Ureaplasma urealyticum infection

A Ureaplasma urealyticum infection is an opportunistic condition caused by *Ureaplasma urealyticum*, a cell wall–deficient bacterium belonging to the Mollicutes class that hydrolyzes urea to generate adenosine triphosphate. Read more about Ureaplasma urealyticum infection

44 drugs 34 manufacturers

Advertisement

Drugs that treat it

Common Ureaplasma urealyticum infection therapies.

Showing 19–27 of 44 drugs

Filter & compare in the drug finder →Opens the drug finder with Ureaplasma urealyticum infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ureaplasma urealyticum infection.

A Ureaplasma urealyticum infection is an opportunistic condition caused by *Ureaplasma urealyticum*, a cell wall–deficient bacterium belonging to the Mollicutes class that hydrolyzes urea to generate adenosine triphosphate.

Primarily colonizing the mucosal surfaces of the human urogenital tract, it can transition into an active pathogen causing non-gonococcal urethritis in men, as well as cervicitis, pelvic inflammatory disease, and chorioamnionitis in women.

Vertical transmission during pregnancy or delivery also places preterm neonates at risk for severe complications, including congenital pneumonia, bacteremia, and bronchopulmonary dysplasia.

Pathophysiologically, disease occurs when mucosal colonization triggers host inflammatory cascades, tissue damage from local ammonia accumulation via urease activity, and cellular disruption by bacterial enzymes.

Personalize your experience

Follow Ureaplasma urealyticum infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it